Mark Lackner
Directeur Technique/Scientifique/R&D chez ZENTALIS PHARMACEUTICALS, INC.
Fortune : 2 M $ au 30/04/2024
Profil
Mark Lackner is currently the Chief Scientific Officer at Zentalis Pharmaceuticals, Inc. He previously worked as the VP, Head-Biology & Translational Sciences at IDEAYA Biosciences, Inc. Dr. Lackner obtained his doctorate degree from Stanford University in 1997.
He also holds undergraduate and graduate degrees from the University of Illinois At Urbana–Champaign, which were conferred in 1990 and 1991 respectively.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/02/2024 | 195 728 ( 0,28% ) | 2 M $ | 30/04/2024 |
Postes actifs de Mark Lackner
| Sociétés | Poste | Début |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/12/2023 |
Anciens postes connus de Mark Lackner
| Sociétés | Poste | Fin |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formation de Mark Lackner
| Stanford University | Doctorate Degree |
| University of Illinois At Urbana–Champaign | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
